A pilot study comparing two polymethylpentene extracorporeal membrane oxygenators

J Rambaud, J Guilbert, I Guellec, S Renolleau - Perfusion, 2013 - journals.sagepub.com
J Rambaud, J Guilbert, I Guellec, S Renolleau
Perfusion, 2013journals.sagepub.com
Objective: We compared two polymethylpentene oxygenators being used in our unit: the
Maquet Quadrox-iD paediatric® and the Medos Hilite 800LT®. Study design: A mono-
centric, prospective pilot study was conducted on ten consecutive newborn patients who had
been admitted to our hospital service for extracorporeal circulation (EC) treatment. We
examined the rate of oxygen transfer, the CO2 removal capacity and the average sweep gas
flow required to produce this result. We also assessed the disturbances of haemostasis, the …
Objective
We compared two polymethylpentene oxygenators being used in our unit: the Maquet Quadrox-iD paediatric® and the Medos Hilite 800LT®.
Study design
A mono-centric, prospective pilot study was conducted on ten consecutive newborn patients who had been admitted to our hospital service for extracorporeal circulation (EC) treatment. We examined the rate of oxygen transfer, the CO2 removal capacity and the average sweep gas flow required to produce this result. We also assessed the disturbances of haemostasis, the need for labile blood products and the membrane oxygenator lifetime and cost of use.
Conclusions
According to our study, it seems to us that Medos Hilite 800LT® membrane oxygenators demonstrate greater oxygen transfer and CO2 removal capacity than Maquet Quadrox-iD paediatric® membrane oxygenators, at a similar cost. These results lead us to conclude that it is reasonable to continue using Medos Hilite 800LT® membrane oxygenators. A broader comparison study would be necessary in order to support these initial results.
Sage Journals
以上显示的是最相近的搜索结果。 查看全部搜索结果